Table 2.
Gastrointestinal symptoms in the cohort.
| Control Group N = 25 | Intervention Group N = 80 | P-Value | |
|---|---|---|---|
| Rome IV criteria | |||
| Baseline | |||
| Unspecified FGID | 6 (24.0) | 11 (13.8) | 0.352 |
| IBS | 19 (76.0) | 67 (83.8) | |
| Mixed IBS | 8 | 29 | 0.270 * |
| IBS-D | 3 | 23 | |
| IBS-C | 7 | 13 | |
| Unspecified IBS | 1 | 2 | |
| Missing value | 2 (2.5) | ||
| 4 weeks | |||
| No FGID/IBS | 23 (28.8) | 0.001 | |
| Unspecified FGID | 7 (28.0) | 9 (11.2) | |
| IBS | 16 (64.0) | 39 (48.8) | |
| Mixed IBS | 5 | 10 | 0.815 * |
| IBS-D | 5 | 17 | |
| IBS-C | 5 | 11 | |
| Unspecified IBS | 1 | 1 | |
| Missing value | 2 (8.0) | 9 (11.2) | |
| IBS-SSS total score | |||
| Baseline | |||
| Moderate | 11 (44.0) | 37 (46.3) | 0.821 |
| Severe | 14 (56.0) | 41 (51.2) | |
| Missing value | 2 (2.5) | ||
| 4 weeks | |||
| <75 | 15 (18.8) | <0.001 | |
| Mild 75–174 | 2 (8.0) | 24 (30.0) | |
| Moderate 175–299 | 9 (36.0) | 24 (30.0) | |
| Severe ≥ 300 | 12 (48.0) | 9 (11.9) | |
| Missing value | 2 (8.0) | 8 (10.0) |
FGID = Functional gastrointestinal disease, IBS = irritable bowel syndrome, IBS-D = diarrhea-predominated IBS, IBS-C = constipation-predominated IBS, IBS-SSS = irritable bowel syndrome – symptom severity scale. Values are presented as number and percentage. * = analyses of IBS subgroups. Fisher’s exact test. P < 0.05 was considered statistically significant.